Introduction {#sec1-1}
============

Posterior circulation ischemia is a common ischemic cerebrovascular disease, accounting for 20% of ischemic stroke, with common symptoms including dizziness, vertigo, and gait or limb ataxia (Bulut et al., 2014; Peng et al., 2014). The most common cause of posterior circulation ischemia involves vertebral artery orifice stenosis, which is mainly induced by atheromatous plaque infiltration (Kocak et al., 2012; Chen et al., 2013). Patients with mild vertebral artery orifice stenosis do not have any symptoms, while aggravation of stenosis can cause significant vertigo. Patients with severe stenosis can exhibit posterior circulation infarction, and previous conservative treatment often cannot reverse this process (Marquardt et al., 2009; Compter et al., 2011).

In recent years, the development of percutaneous transluminal angioplasty and stenting has provided potential treatments for patients with vertebral artery orifice stenosis. Suitable stent implantation to the site of stenosis can reconstruct the original form of the vertebral artery and improve blood supply to the brain (Li et al., 2014). Numerous studies have reported the therapeutic effects of vertebral artery orifice stenting (Antoniou et al., 2012; Edgell et al., 2013). Percutaneous transluminal angioplasty and stenting have been shown to apparently improve blood supply to the posterior circulation, with mitigation of patient\'s clinical symptoms. However, previous studies have mainly focused on the recovery of cerebral blood flow and cerebral perfusion in the posterior circulation of the brain after interventional therapy, but seldom addressed the functional recovery of local brain tissue.

Blood oxygen level-dependent functional magnetic resonance imaging can provide a measure of regional brain function remodeling and restructuring (Lukas et al., 2013; Pugnaghi et al., 2014). Thus, in the present study, we examined the effects of interventional therapy on cerebellar function remodeling using blood oxygen level-dependent functional magnetic resonance imaging in patients undergoing vertebral artery orifice angioplasty and stenting for severe vertebral artery orifice stenosis.

Subjects and Methods {#sec1-2}
====================

Subjects {#sec2-1}
--------

A total of 40 patients with severe unilateral vertebral artery orifice stenosis, who were treated in the Department of Neurology, Yongchuan Hospital, Chongqing Medical University, China from January 2013 to June 2014, were enrolled in this study. Patients were equally and randomly divided into the intervention group (9 males and 11 females) and control group (10 males and 10 females). Patient\'s age and course of disease are listed in [**Table 1**](#T1){ref-type="table"}.

###### 

Baseline data of patients

![](NRR-9-2095-g001)

### Inclusion criteria {#sec3-1}

\(1\) Patients or their families signed the informed consent; (2) age of 50--79 years, irrespective of gender; (3) disease onset had the symptoms of posterior circulation ischemia, such as dizziness, vertigo, or unsteady gait, with no signs of paralysis of limbs before and after the disease; (4) clinical diagnosis: posterior circulation ischemia, but no posterior circulation infarction detected by CT or MRI; (5) CT angiography, magnetic resonance angiography or digital subtraction angiography revealed severe unilateral vertebral artery orifice stenosis, with a stenosis rate of ≥ 70%. No stenosis was found in the contralateral vertebral artery and basilar artery. Left or right vertebral artery stenosis is shown in [**Figure 1A**](#F1){ref-type="fig"} and [**Figure 2A**](#F2){ref-type="fig"}. (6) Agreed to receive blood oxygen level-dependent functional magnetic resonance imaging.

![Cerebral angiography images and functional MRI images before and after drug treatment (1 and 14 days after hospitalization) in a case of severe right vertebral artery orifice stenosis of the control group.\
A 64-year-old female patient hospitalized because of vertigo recurring for 1 month. Cerebral angiography revealed severe right vertebral artery orifice stenosis on the day of hospitalization (green arrow), with a stenosis rate of approximately 80% (A). The patient entered the control group during preliminary screening, was unwilling to accept the interventional treatment, and was then enrolled in the control group. (B--E) Functional MRI on 1 day of hospitalization revealed that motor cortex in 4 and 6 regions of the bilateral cerebral hemispheres and bilateral cerebellar cortex were activated (yellow arrows). Simultaneously, the cortices of other parts of the bilateral frontal lobe, bilateral parietal lobe, temporal lobe, occipital lobe, and insula were activated to different degrees (red). The range and area of the activated regions were similar between the control and intervention groups. (F--I) Functional MRI was performed at 14 days after hospitalization (simple drug treatment), resulting in various degrees of activation of various brain regions (red). For example, the area of activated cerebellar cortex was increased (yellow arrows), although the improvement was not as evident as that in the intervention group. (B, F) Three-dimensional whole-brain cortex activation. (C, G) Cross-section of activated cortex. (D, H) Coronal section of activated cortex. (E, I) Sagittal section of activated cortex. R: Right; L: left; green A: anterior; P: posterior.](NRR-9-2095-g002){#F1}

![Cerebral angiography images before and after stenting and functional MRI images before and after interventional therapy (1 and 14 days after hospitalization) in a case of severe left vertebral artery orifice stenosis of the intervention group.\
A 70-year-old male patient hospitalized because of vertigo recurring for 20 days. CT cerebral angiography at out-patient clinic revealed severe left vertebral artery orifice stenosis. At 3 days after hospitalization, he was subjected to left vertebral artery orifice angioplasty and stenting. (A) Radiography showed severe left vertebral artery orifice stenosis, with a stenosis rate of approximately 90% (green arrow). (B) During stenting, an unreleased stent is located in the region of stenosis (green arrow). (C) After stenting, vascular stenosis was eliminated, and no obvious residual stenosis was found (green arrow). (D--G) Functional MRI was performed at 1 day after hospitalization, and results exhibited activation of the motor cortex in 4 and 6 regions of the bilateral cerebral hemispheres and bilateral cerebellar cortex (yellow arrows). Simultaneously, the cortices of other parts of the bilateral frontal lobe, bilateral parietal lobe, temporal lobe, occipital lobe, and insula were activated to different degrees (red). The range and area of the activated areas were similar between the intervention and control groups. (H--K) The patient received functional MRI after interventional therapy at 14 days after hospitalization, resulting in different degrees of activation in various brain regions (red). For example, the area of activated cerebellar cortex was increased (yellow arrows), and the increase was more evident than in the control group. (D, H) Three-dimensional whole-brain cortex activation. (E, I) Cross-section of activated cortex. (F, J) Coronal section of activated cortex. (G, K) Sagittal section of activated cortex. R: Right; L: left; green A: anterior; P: posterior.](NRR-9-2095-g003){#F2}

### Exclusion criteria {#sec3-2}

\(1\) Combined with cardiovascular diseases (acute myocardial infarction, angina, and paroxysmal tachycardia); (2) combined with severe primary liver and kidney diseases; (3) hyperthyroidism; (4) cerebral hemorrhage within 2 weeks; (5) other bleeding tendency or massive blood loss recently; (6) mental disorders; (7) disturbance of intelligence, such as dementia; (8) donors thought the patient who should not be enrolled; (9) we found during the study that the patient did not comply with the study protocol, the treatment was discontinued for some reason, or we could not evaluate the therapeutic effects; (10) refused to receive blood oxygen level-dependent functional magnetic resonance imaging, or researchers believed that the patient needed to withdraw from the study.

### Grouping principles {#sec3-3}

\(1\) After fully understanding the study design and aims, the patients and families agree to enter this clinical study, and they were randomly grouped; (2) the patients entered the control group during preliminary screening; patients were unwilling to accept the interventional treatment for personal reasons, and were enrolled in the control group; patients were willing to accept the interventional treatment and quit the control group; (3) the patients entered the intervention group during preliminary screening, were willing to accept the interventional treatment, and were enrolled in the intervention group. The patients who were unwilling to accept the interventional treatment quit the experiment.

Treatments {#sec2-2}
----------

Subjects in the control group were administered drugs for 2 weeks immediately on the day of hospitalization. Medicine contained 600 mg gastrodin injection (Harbin Shengtai Biological Pharmaceutical Co., Ltd., Harbin, Heilongjiang Province, China) in 250 mL physiological saline by intravenous drip, once a day, 500 mg citicoline injection (Changchun Tiancheng Pharmaceutical Co., Ltd., Changchun, Jilin Province, China) in 100 mL physiological saline by intravenous drip, once a day, 100 mg aspirin enteric-coated tablets (Jiangsu Pingguang Pharmaceutical Co., Ltd., Xuzhou, Jiangsu Province, China) orally, once a day, and 75 mg clopidogrel (Hangzhou Sainuofei Pharmaceutical Co., Ltd., Hangzhou, Zhejiang Province, China) orally, once a day.

Subjects in the intervention group received these medicines and underwent vertebral artery orifice angioplasty and stenting at 3--5 days after hospitalization under local anesthesia. Before the surgery, subjects were required to take oral aspirin or clopidogrel for more than 3 days. For the surgical methods, a 6F vascular sheath was inserted into the femoral artery. A 6F guiding catheter was inserted into the subclavian artery (near the narrow vertebral artery orifice) under the guide of an 0.89-mm super-slippery guidewire. A 0.35-mm micro guidewire through the head end of the narrow blood vessels was placed in the V3 segment of the vertebral artery. Under the guide of a micro guidewire, a Boston balloon expandable stent (Boston Scientific, Castle Rock, CO, USA; made by platinum chromium alloy) was placed at the lesion site for expansion until stenosis was \< 30%. Postoperative conventional treatment is shown in [**Figure 1A**](#F1){ref-type="fig"} and **Figure [2A](#F2){ref-type="fig"}--[C](#F2){ref-type="fig"}**.

Observation index {#sec2-3}
-----------------

Each patient was observed for 2 weeks. The patients who hospitalized for more than 2 weeks were no longer studied after this time. The patients lost to follow up were excluded, and were supplemented by new subjects (two cases in the intervention group and three cases in the control group). Clinical efficacy of each patient was evaluated using Dizziness Handicap Inventory (DHI) at 1 and 14 days after hospitalization. DHI is an internationally recognized method of assessing the severity of vertigo. This scale contains 25 questions, with a score range of 0--100; score 0 represents normal. A high score indicates a severe degree of vertigo (Alsanosi, 2012; Mutlu and Serbetcioglu, 2013; Georgieva-Zhostova et al., 2014).

Blood oxygen level-dependent functional magnetic resonance imaging was conducted at 1 and 14 days of hospitalization in each patient, as previously described (Li et al., 2012; Wang et al., 2012). Imaging was performed in a block design, with rest (base-line) and stimulus (task) alternated with each other. After 12 seconds of preparation, the patients performed a flexion and extension task with their hands (task condition), once every 3 seconds, for a total of 15 times over 30 seconds. Subjects then rested for 30 seconds. This task/rest paradigm was repeated a total of three times. Simultaneously, blood oxygen level-dependent functional magnetic resonance imaging was conducted. Two three-dimensional images of blood oxygen level-dependent functional magnetic resonance imaging were obtained in each patient before and after treatment. Activation of the cerebellar cortex and cerebral cortex was observed from the three-dimensional images. The area of activated cerebellar cortex was measured using the MRI software, and the images were compared before and after treatment for each patient. Changes in cerebellar cortex activation in each patient were calculated by the area of activated cerebellar cortex at 14 days after hospitalization -- the area of activated cerebellar cortex at 1 day after hospitalization. Differences in the improvement value of cerebellar cortex activation were compared between the two groups. The effect of remodeling of the vertebral artery orifice angioplasty and stenting on cerebellar function was also assessed.

Statistical analysis {#sec2-4}
--------------------

Measurement data were expressed as the mean ± SD, and numeration data were presented by percentage. Data were analyzed using SPSS 20.0 software (SPSS, Chicago, IL, USA). The differences in age, course of disease, DHI score, the improvement value of DHI score, the area of activated cerebellar cortex, and the improvement value of cerebellar cortex activation between groups were compared using two-sample t-test. Gender composition between groups was compared using chi-square test. Alpha was set to 0.05.

Results {#sec1-3}
=======

Clinical efficacy of stenting for severe vertebral artery orifice stenosis {#sec2-5}
--------------------------------------------------------------------------

No significant differences in gender composition ratio, age, or course of disease were found between the intervention and control groups ([**Table 1**](#T1){ref-type="table"}; *P* \< 0.05). All patients experienced symptoms of posterior circulation ischemia such as varying degrees of dizziness and vertigo at 1 day after hospitalization. No significant differences in average DHI score were detectable between the intervention and control groups ([**Table 2**](#T2){ref-type="table"}). Significant differences in average DHI score in the intervention and control groups were detected at 13 days after treatment (14 days after hospitalization) compared with pre-treatment (*P* \< 0.05), and there were significant differences between the two groups at this time (*P* \< 0.05; [**Table 2**](#T2){ref-type="table"}). The mean improvement value of DHI score was significantly greater in the intervention group than in the control group (*P* \< 0.05; [**Table 2**](#T2){ref-type="table"}).

###### 

Differences in DHI score and the area of activated cerebellar cortex before and after treatment in the intervention and control groups

![](NRR-9-2095-g004)

Imaging evaluation of stenting for severe vertebral artery orifice stenosis {#sec2-6}
---------------------------------------------------------------------------

Blood oxygen level-dependent functional magnetic resonance imaging results during patient hand movement at before (1 day after hospitalization) and after treatment (14 days after hospitalization) demonstrated evidence of motor cortex activation in 4 and 6 regions of the bilateral cerebral hemispheres and the bilateral cerebellar cortex activation. Simultaneously, the cortices of other parts of the bilateral frontal lobe, bilateral parietal lobe, temporal lobe, occipital lobe, and insula were activated to different degrees (**Figures** [**1**](#F1){ref-type="fig"} and [**2**](#F2){ref-type="fig"}).

The measurement results of the surface area of activated cerebellar cortex using the MRI software before and after treatment in each patient are shown in [**Table 2**](#T2){ref-type="table"}. At 1 day after hospitalization, the cerebellar cortex was activated in both groups, while no significant differences in the mean area of the activated cerebellar cortex were detected between the intervention and control groups. The mean area of activated cerebellar cortex in the two groups was significantly larger at 13 days of treatment compared with pre-treatment (*P* \< 0.05). Significant differences in the mean area of activated cerebellar cortex were observed between the two groups after treatment (*P* \< 0.05; [**Table 2**](#T2){ref-type="table"}). The mean of improvement value of activated cerebellar cortex was significantly greater in the intervention group than that in the control group (*P* \< 0.05; [**Table 2**](#T2){ref-type="table"}).

Discussion {#sec1-4}
==========

Posterior circulation ischemia can have marked effects on patients, including dizziness and vertigo, limb or head and facial numbness, limb weakness, headache, vomiting, diplopia, transient loss of consciousness, visual disturbances, unsteady gait or falling, or even death (Ito et al., 2010; Wang et al., 2011; Choi et al., 2012). Posterior circulation ischemia is an ischemic cerebrovascular disease induced by severe vertebral artery orifice stenosis. In the acute stage, treatment is typically provided using the organized stroke care model, involving antiplatelet and anticoagulant drug therapy, supplemented with neuroprotective agents and symptomatic drugs, while secondary thrombosis is treated by ultra-early thrombolytic therapy (Amole et al., 2012). For convalescent treatment, anti-platelet aggregation, plaque-stabilizing drugs, and controlling the risk factors for hypertension, diabetes, and hyperlipemia are commonly used (Amole et al., 2012; Koch et al., 2014). However, as vertebral artery stenosis is often caused by hard plaque infiltration, the drug treatment can reduce the clinical symptoms acutely, but is unable to fundamentally improve the narrow anatomical structures (Kim et al., 2013).

Surgical treatment for severe vertebral artery orifice stenosis is not ideal. Wehman et al. (2004) reported an endarterectomy on the vertebral artery origin through the vertebral artery wall or the subclavian artery. There are also a few cases of successful posterior circulation extracranial-intracranial bypass grafting, although the rate of relative complications is high, and this technique is not widely used clinically. Endovascular treatment has also been used for stenosis. Higashida et al. (1993a, b) confirmed that the incidence of postoperative neurological dysfunction was 8.8% in 34 vertebral artery origin stenosis patients undergoing percutaneous transluminal angioplasty, and the incidence of restenosis was 8.8% 5 months later. Bruckmann et al. (1986) verified that the long-term restenosis rate of percutaneous transluminal angioplasty without stenting reached 15--30%. Therefore, balloon angioplasty alone is no longer recommended because of its ease of recoil and high restenosis rate. Nevertheless, the combination of balloon angioplasty with stenting is becoming increasing popular. Stenting itself can reduce the rate of restenosis after percutaneous transluminal angioplasty, and numerous studies have examined the clinical therapeutic effects of combination treatment (Mohammadian et al., 2013; Sakamoto et al., 2013). In the present study, the improvement value of the DHI score and cerebellar cortex activation were higher in the intervention group than in the control group, indicating the recovery of ischemic cerebellar function. Thus, combination balloon angioplasty and stenting is an appropriate treatment method for severe vertebral artery orifice stenosis.

Blood oxygen level-dependent functional magnetic resonance imaging directly reflects the activation of the human brain, and has been extensively used in clinical studies of brain remodeling (Chao et al., 2014; Galazzo et al., 2014; Zhang et al., 2014). However, these studies have generally focused on the cerebral hemispheres, rather than the cerebellum. Posterior circulation ischemia can directly affect cerebellar function. Blood oxygen level-dependent functional magnetic resonance imaging has been shown to effectively detect the activated domain of the cerebellar cortex, which can be used to directly assess cerebellar reorganization and remodeling. Our results demonstrated that interventional therapy effectively promoted cerebellar function remodeling in patients with severe vertebral artery orifice stenosis.

The bilateral internal carotid arteries and the vertebral artery supply blood to intracranial brain tissues. The internal carotids account for 80--90% the total blood supply of the brain, while the vertebral artery accounts for 10--20%. When the unilateral or bilateral vertebral artery blood flow is reduced by stenosis or occlusion, clinical evidence of ischemia would not be observed if the posterior communicating artery or other collateral arteries are open. Nevertheless, in many normal subjects, the posterior communicating artery was reported to be not opened or exhibit hypoplasia (Morris and Choi, 1996; Burgess et al., 1999). Thus, these subjects would be highly sensitive to posterior circulation ischemia. When vertebral artery stenosis accounts for more than 80% of the lumen cross-sectional area, cerebral blood flow is reduced in the posterior circulation. When cerebral blood flow is below a critical level (18--20 mL/100 g per minute), cerebral ischemia would occur (Abe et al., 2014; Chi et al., 2014). The cases in the present study exhibit these conditions, and interventional therapy is considered an effective treatment method.

In chronic cerebral ischemia, a range of pathophysiological changes occur in the brain, including energy metabolism dysfunction, decreased glucose decreased use, abnormal protein synthesis, neurotransmitter changes, cholinergic receptor deletion, white matter damage, and neuronal defects (Macdonald and Stoodley, 1998; Villringer and Dirnagl, 1999). These changes ultimately lead to functional decline in brain tissue, thus reducing the areas of activation in the cortex. The methods described in the present study are currently used for treatment of brain injury induced by chronic cerebral ischemia (Nagahiro et al., 1998). For example, cilostazol inhibits glial cell changes in brain cells, osthole reduces oxidation in brain tissue, succinylcholine regulates neurotransmitter disorders, and anticoagulant and antiplatelet drugs improve cerebral ischemia. Additionally, glutamate antagonists, glutamate release inhibitors, free radical scavengers, and cell membrane stabilizers can be neuroprotective. Traditional Chinese medicine preparations for promoting blood circulation and removing blood stasis are also used (Behravan et al., 2014; Chen et al., 2014; Sun et al., 2014; Tang et al., 2014). Further, stem cells and vascular endothelial growth factor have therapeutic effects on chronic cerebral ischemia (Gu et al., 2014; Song et al., 2014; Yang et al., 2014). However, these treatment methods are conservative and passive, and although they can improve metabolism and clinical symptoms of ischemic brain tissue acutely, they do not remove the underlying causes of cerebral ischemia. Thus, the symptoms of chronic cerebral ischemia may recur.

Percutaneous transluminal angioplasty and stenting for cerebrovascular stenosis can rebuild normal vascular morphology, remove the actual cause of chronic cerebral ischemia, and provide therapeutic benefits. Although ischemia/reperfusion injury may appear in distal brain tissue in the early stage after percutaneous transluminal angioplasty and stenting, ischemic brain tissue can adapt to the sufficient blood flow within several days. Local micro-circulation and metabolism gradually return to normal, followed by improved brain function indicated by enlarged areas of activation in the cortex (Han et al., 2013; Jiang et al., 2014). Thus, interventional therapy can effectively promote cerebellar function remodeling in patients with severe vertebral artery orifice stenosis.

In summary, both drugs and interventional methods can provide therapeutic effects in severe vertebral artery orifice stenosis patients with posterior circulation ischemia. However, compared with drug treatment, interventional therapy can eliminate the fundamental aspects of the disease, and promote the remodeling of ischemic brain tissue.
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